Relation Between Oxidant/Antioxidant Status and Postpartum Anestrous Conditions

The aim of the present study was to detect the relation between oxidant/antioxidant status and postpartum anestrous (PPA) conditions in dairy cows.The postpartum period is a very critical time that influenced mainly in cattle reproduction. A little information is obtainable in literature concerning antioxidant defense mechanisms during anestrus.The purpose of the following study is detection of the relation between oxidant/antioxidant status and postpartum anestrous (PPA) condition in dairy cows. Seventy five postpartum anestrous (PPA) and twenty five normal cyclic Holstein Friesian pluriparous dairy cows were selected on the basis of their reproductive history gained from farm records. Depend on the rectal findings and ultrasonography in addition to progesterone profile the studied animals were classified into three groups (each 25 animals) as inactive ovaries group, persistent corpus luteum group and silent heat group. Blood samples from anestrous and normal cyclic animals were gathered at day 0, day 10, day 21. These samples were utilized for detection of MDA, Vitamin C, Nitric Oxide and Total antioxidant capacity. Results of the present study revealed that MDA and Nitric Oxide were be significantly (plt0.05) higher in the groups of PPA than the normal cyclic group. Vitamin C (Ascorbic acid)nbsp levels were seen to be significantly (plt0.05) lower in normal cyclic animals in comparison to inactive ovaries group and persistent C.L group ,while there is no significant difference with the silent heat group . No statistically significant difference was detected in the total antioxidant capacity between the group of silent heat and the normal cyclic group, while the groups of persistent C.L and inactive ovaries were found to have statistically significant difference (plt0.05) with the normal cyclic group. It is concluded that supplementing diets with optimal levels of micronutrients with antioxidant capabilities is a good advice to farmers to avoid post-partum anestrum. Moreover, early approaches to conflict the progression of stress and to promote the antioxidant defense mechanisms of dairy cattle during times of increased metabolic demands appears to be Pertinent

In vitro Activity of the Aqueous Extract of the Plant Kigelia africana Against Theileria lestoquardi

The objective of this study was to test the activity of the aqueous extract of the plant Kigelia africana against Theileria lestoquardi, the causative agent of malignant ovine theileriosis. Aqueous extract of K. africana fruits was screened for its in vitro activity against T. lestoquardi at different concentrations of 250, 500, 5000 and 10000 ppm. Lymphocytes infected with T. lestoquardi were isolated from heparinized blood with Ficoll-paque, grown in minimum essential medium and continuously sub cultured until passage 8 which was used for the test. The parasite was identified, using indirect fluorescent antibody test. The results revealed in vitro activities of 20%, 58% and 80% at concentrations of 500, 5000 and 10000 ppm, respectively. Lethal dose 50% and 99% (LC50 and LC99) were 2660.28 and 29980.34 ppm, respectively. The extract activity caused significantly (P≤0.05) high death of macroschizonts, decrease in the number of macroschizonts per cell, and increase in the number of extra cellular macroschizonts at concentrations of 5000 and 10000 ppm. The number of dividing cells significantly (P≤0.05) decreased at concentrations of 500, 5000 and 10000 ppm. The number of viable cells, also, significantly (P≤0.05) decreased at concentrations of 5000 and 10000 ppm compared with the control which did not significantly (P>0.05) increase. Besides, the activity of the highest concentration (10000 ppm) revealed some lymphoblast cells with degenerated nuclei. The study showed that K. africana has antitheilerial effect on T. lestoquardi and could be an effective candidate for the treatment of malignant ovine theileriosis after in vivo confirmation. Further studies are recommended for phytochemical analysis and mode of action

THE POWER OF AIRPORT BRANDING IN SHAPING TOURIST DESTINATION IMAGE: PASSENGER COMMITMENT PERSPECTIVE

To providing an empirical investigation into how affective, continuance, and normative commitment could build airport branding. A quantitative content analysis was conducted by analyzing 400 passengers' reviews of Cairo International Airport from the following platforms (Skytrax, Tripadvisor, traveller, and flight report). Affective and continuance commitment are likely to build a strong brand rather than normative commitment. Passengers’ negative experiences with airports make them feel less emotionally attached, resulting in lower levels of affective and continuance commitments. Terminal problems can decrease affective and continuance commitment among passengers. The study identified factors that affect all three types of commitments (affective, continuance, and normative) at international airports, providing significant theoretical contributions and managerial implications

Tuning the Chemical Environment within the UiO-66-NH2 Nanocages for Charge-Dependent Contaminant Uptake and Selectivity

The remarkable water stability of Zr-carboxylatebased metal-organic frameworks (MOFs) stimulated considerable interest toward their utilization in aqueous phase applications. The origin of such stability is probed here through pH titration and plc modeling. A unique feature of the Zr-6(mu 3OH)(4)(mu O-3)(4)(RCO2)(12) cluster is the Zr-bridging oxo/hydroxyl groups, demonstrating several pK(a) values that appear to provide for the water stability at a wide range of pH. Accordingly, the tunability of the cage/surface charge of the MOF can feasibly be controlled through careful adjustment of solution pH. Such high stability, and facile control over cage/surface charge, can additionally be augmented through introducing chemical functionalities lining the cages of the MOF, specifically amine groups in the UiO-66-NH2 presented herein. The variable protonation states of the Zr cluster and the pendant amino groups, their H-bond donor/acceptor characteristics, and their electrostatic interactions with guest molecules were effectively utilized in controlled experiments to demonstrate high uptake of model guest molecules (137 mg/g for Cr(VI), 1275 mg/g for methylene blue, and 909 mg/g for methyl orange). Additionally, a practical form of the silica-supported MOF, UiO-66-NH2 @SiO2, constructed in under 2 h reaction time, is described, generating a true platform microporous sorbent for practical use in demanding applications

A Compact Flexible and Frequency Reconfigurable Antenna for Quintuple Applications

A novel, compact coplanar waveguide fed flexible antenna is presented. The proposed design uses flexible Rogers RT/duroid 5880 (0.508mm thickness) as a substrate with small size of 30×28.4 mm^2. Two switches are integrated on the antenna surface to change the current distribution which consequently changes the resonance frequency under different conditions of switches, thereby making it a frequency reconfigurable antenna. The antenna design is simulated on CST®MWS®. The proposed antenna exhibits VSWR<2 and appreciable radiation patterns with positive gain over desired frequency bands. Good agreement exists between simulated and measured results. On the basis of results, the proposed antenna is envisioned to be deployed for the following applications; aeronautical radio navigation [4.3 GHz, AMT fixed services [4.5 GHz, WLAN [5.2 GHz, Unlicensed WiMAX [5.8 GHz and X-band [7.5 GHz

Myocardial infarction following COVID-19 vaccine administration; a systematic review.

IntroductionCovid-19 vaccines have been assessed in randomized trials, which are designed to establish efficacy and safety, but are insufficient in power to detect rare adverse outcomes. Among the adverse cardiac events associated with mRNA COVID-19 vaccines are inflammations (e.g., pericarditis or myocarditis), thrombosis, and ischemia.ObjectiveThis systematic review aims to evaluate the reported cases of myocardial infarction (MI) after COVID-19 vaccinations.MethodWeb of Science, MEDLINE on OVID, PubMed, and Google Scholar were searched for English-language papers published until March 25, 2022.ResultsThis study included 15 papers (10 case reports and 5 case series). In total, 20 individuals were included who had received COVID-19 vaccines and experienced MI. Males (55%) reported more adverse occurrences than females (45%) across the majority of event categories. The mean time from the administration of the vaccine to the onset of symptoms was 2 days (0-10 days). The AstraZeneca vaccine was responsible for more than half of the reported events. In the majority of cases, the event developed after receiving the first dose of vaccination.ConclusionMI related to COVID19 vaccination is a rare, but serious and life-threatening condition. Chest discomfort should be regarded as a warning sign, particularly in people who have been administered a dose of the vaccine within the previous two days

Development of polymeric nanocomposite (Xyloglucan-co-Methacrylic acid/Hydroxyapatite/SiO 2 ) scaffold for bone tissue engineering applications—In-vitro antibacterial, cytotoxicity and cell culture evaluation

Advancement and innovation in bone regeneration, specifically polymeric composite scaffolds, are of high significance for the treatment of bone defects. Xyloglucan (XG) is a polysaccharide biopolymer having a wide variety of regenerative tissue therapeutic applications due to its biocompatibility, in-vitro degradation and cytocompatibility. Current research is focused on the fabrication of polymeric bioactive scaffolds by freeze drying method for nanocomposite materials. The nanocomposite materials have been synthesized from free radical polymerization using n-SiO2 and n-HAp XG and Methacrylic acid (MAAc). Functional group analysis, crystallinity and surface morphology were investigated by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD) and scanning electron microscopy (SEM) techniques, respectively. These bioactive polymeric scaffolds presented interconnected and well-organized porous morphology, controlled precisely by substantial ratios of n-SiO2. The swelling analysis was also performed in different media at varying temperatures (27, 37 and 47 °C) and the mechanical behavior of the dried scaffolds is also investigated. Antibacterial activities of these scaffolds were conducted against pathogenic gram-positive and gram-negative bacteria. Besides, the biological behavior of these scaffolds was evaluated by the Neutral Red dye assay against the MC3T3-E1 cell line. The scaffolds showed interesting properties for bone tissue engineering, including porosity with substantial mechanical strength, biodegradability, biocompatibility and cytocompatibility behavior. The reported polymeric bioactive scaffolds can be aspirant biomaterials for bone tissue engineering to regenerate defecated bone

Immunomodulatory effect of Premna odorata volatile oils in Mycobacterium tuberculosis by inhibiting TLR4/NF-κB pathway

Introduction: The development of multi drug resistant (MDR) tuberculosis (TB) and extensively drug resistant (XDR) TB, increased the interest in the usage of medicinal plants that are complementary to antibiotics to improve anti-TB efficacy. The present study aimed to confirm the anti-TB efficacy of volatile oils (VOs) isolated from different parts of Premna odorata in vivo, and moreover, to test the possible involvement of TLR4/NF-κB signaling pathway in its anti-TB efficacy. Methods: Thirty mice were divided into six equal groups. Group 1: healthy mice (negative control). Groups 2-6 were injected intravenously with a positive TB solution of purified MeDiPro Mycobacterium tuberculosis (MTB) antigen for 7 days to induce tuberculosis. Group 3-6: TB-injected mice treated respectively with leaves VO (300 μL/d), young stems VO (300 μL/d), flowers VO and a combination of the three essential VOs (1:1:1). Various immunologic factors and antioxidant activity were evaluated and compared in the groups. Results: TB-infected mice showed a significant increase in the serum levels of tumor necrosis factor-α (TNF-α), interferon-gamma (IFN-γ), interleukin (IL) 1-β and the mRNA expression levels of toll-like receptor 4 (TLR-4) & nuclear factor-κB (NF-κB) and a decrease in IL-10 & total antioxidant capacity (TAC). While pretreatment with VOs extracted from leaves, flowers, young stems and a combination of the three oils reversed these effects. Conclusion: The immunomodulatory effects of VOs extracted from different parts of P. odorata against TB infection involve the TLR-4/NFκB signaling pathway as well as, antioxidant effects, recommending that the use of this plant may help TB infected patients

Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience

Background Randomized clinical trials have failed to prove that the safety and efficacy of endovascular treatment for symptomatic intracranial atherosclerotic disease (ICAD) is better than that of medical management. A recent study using a self-expandable stent showed acceptable lower rates of periprocedural complications. Objective To study the safety and efficacy of a balloon-mounted stent (BMS) in the treatment of symptomatic ICAD. Methods Prospectively maintained databases from 15 neuroendovascular centers between 2010 and 2020 were reviewed. Patients were included if they had severe symptomatic intracranial stenosis in the target artery, medical management had failed, and they underwent intracranial stenting with BMS after 24 hours of the qualifying event. The primary outcome was the occurrence of stroke and mortality within 72 hours after the procedure. Secondary outcomes were the occurrence of stroke, transient ischemic attacks (TIAs), and mortality on long-term follow-up. Results A total of 232 patients were eligible for the analysis (mean age 62.8 years, 34.1% female). The intracranial stenotic lesions were located in the anterior circulation in 135 (58.2%) cases. Recurrent stroke was the qualifying event in 165 (71.1%) while recurrent TIA was identified in 67 (28.9%) cases. The median (IQR) time from the qualifying event to stenting was 5 (2–20.75) days. Strokes were reported in 13 (5.6%) patients within 72 hours of the procedure; 9 (3.9%) ischemic and 4 (1.7%) hemorrhagic, and mortality in 2 (0.9%) cases. Among 189 patients with median follow-up time 6 (3–14.5) months, 12 (6.3%) had TIA and 7 (3.7%) had strokes. Three patients (1.6%) died from causes not related to stroke. Conclusion Our study has shown that BMS may be a safe and effective treatment for medically refractory symptomatic ICAD. Additional prospective randomized clinical trials are warranted